Phase 2
Completed N=13
Treatment for Calcium Phosphate Kidney Stone Disease
Calcium Phosphate Kidney Stones
Source: ClinicalTrials.gov NCT01754779 ↗
Enrolled (actual)
13
Serious AEs
0.0%
Results posted
Apr 2024
Primary outcomePrimary: Urinary Calcium Phosphate Saturation — 2.38; 1.97; 2.19 no units
Summary
The investigators will examine in two studies whether citric acid or potassium citrate can reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Urinary Calcium Phosphate Saturation |
2.38; 1.97; 2.19 | — |
Eligibility Criteria
Inclusion Criteria
Aim 1
- Hypocitraturic CaP stone formers
- urine citrate 21 years
Aim 2
- Hypercalciuric CaP stone formers
- 24hr urine calcium >250mg/d in women and >300mg/d in men prior to indapamide use
- high pH as >6.40 in the absence of urinary tract infection
- >21 years
Data sourced from ClinicalTrials.gov (NCT01754779). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.